相关实验视频

Updated: Jun 11, 2025

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

开发可吸收酸盐基玻璃微球作为MRI对比媒体代理

Jesús Molinar-Díaz^1,2, Andi Arjuna^1,3, Nichola Abrehart⁴

¹Advanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK.

Molecules (Basel, Switzerland)

|September 28, 2024

概括

研究人员开发了可吸收酸盐基玻璃 (PBG) 微球,其中含有不同金属氧化物. -PBG微球显示了增强的MRI放松率,这表明了治疗神经应用的潜力.

科学领域:

生物材料科学生物材料科学
材料化学材料化学
医疗成像医学成像

背景情况:

可吸收酸盐基玻璃 (PBG) 是一个有前途的生物材料.
开发具有可控制属性的PBG对于高级应用至关重要.
研究金属氧化物修饰剂 (Fe,Cu,Mn) 的定制功能.

研究的目的:

通过火焰球化合成和表征可再吸收的PBG微球.
评估这些微球的结构,化学和降解特性.
通过测量放松率来评估它们作为MRI对比剂的潜力.

主要方法:

火焰球化以产生固体和多孔的PBG微球.
使用SEM,XRD,EDX和NMR进行表征.
在28天内进行的体外降解研究.
在1.5T和7T的MRI放松度测量 (R1和R2)

主要成果:

密且多孔的PBG微球与不同的金属氧化物已成功制造.
降解研究显示,质量损失,颗粒大小或pH值没有显著差异.
与铁和铜变体相比,基于的PBG微球显示出显著增强的R2和R1放松率.
增强的放松性归因于对磁性离子.

结论:

可再吸收的PBG微球可以通过火焰球化有效地产生.
添加的PBG微球显示出作为MRI对比剂的潜力.
PBG微球的多孔性为药物输送提供了机会,推进了治疗能力.

关键词:

磁共振成像技术磁共振成像技术口服对比剂是一种口服对比剂.用酸盐为基础的玻璃有孔的微球是有孔的微球.可以再吸收的材料.

更多相关视频

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...